ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$37.850-0.750 (-1.943%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$38.600

High

$39.310

Low

$37.770

Volume

1.40M

Company Fundamentals

Market Cap

5.2B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

2.39M

Exchange

NMS

Currency

USD

52-Week Range

Low $9.57Current $37.850High $43.69

Related News

BusinessWire

Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming events: American Heart Association (AHA) Scientific Sessions 2025 – November 7-10,

View more
Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences
BusinessWire

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that as an inducement to entering into employment with the Company, on October 24, 2025, the Company's Board of Directors approved "inducement" grants to 84

View more
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BusinessWire

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that a global licensing and collaboration agreement with Novartis, previously announced on September 2, 2025, has now closed. Closing of the transaction was

View more
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis